Citadel Advisors’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.2M | Buy |
1,402,768
+890,879
| +174% | +$9.04M | ﹤0.01% | 1159 |
|
|
2025
Q1 | $2.86M | Buy |
511,889
+475,463
| +1,305% | +$2.65M | ﹤0.01% | 2253 |
|
|
2024
Q4 | $294K | Buy |
36,426
+30,659
| +532% | +$247K | ﹤0.01% | 4535 |
|
|
2024
Q3 | $59.1K | Buy |
+5,767
| New | +$59.1K | ﹤0.01% | 5068 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6558 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6662 |
|
|
2023
Q4 | – | Sell |
-145,007
| Closed | -$877K | – | 6447 |
|
|
2023
Q3 | $877K | Buy |
145,007
+66,732
| +85% | +$404K | ﹤0.01% | 3174 |
|
|
2023
Q2 | $607K | Sell |
78,275
-41,328
| -35% | -$321K | ﹤0.01% | 3457 |
|
|
2023
Q1 | $682K | Buy |
119,603
+40,970
| +52% | +$234K | ﹤0.01% | 3562 |
|
|
2022
Q4 | $463K | Buy |
78,633
+66,196
| +532% | +$390K | ﹤0.01% | 3930 |
|
|
2022
Q3 | $40K | Sell |
12,437
-187,950
| -94% | -$604K | ﹤0.01% | 5380 |
|
|
2022
Q2 | $898K | Sell |
200,387
-30,300
| -13% | -$136K | ﹤0.01% | 3518 |
|
|
2022
Q1 | $1.23M | Buy |
+230,687
| New | +$1.23M | ﹤0.01% | 3544 |
|
|
2021
Q4 | – | Sell |
-15,377
| Closed | -$322K | – | 6953 |
|
|
2021
Q3 | $322K | Sell |
15,377
-3,938
| -20% | -$82.5K | ﹤0.01% | 4963 |
|
|
2021
Q2 | $342K | Buy |
+19,315
| New | +$342K | ﹤0.01% | 5077 |
|
|
2021
Q1 | – | Sell |
-40,435
| Closed | -$1.37M | – | 6657 |
|
|
2020
Q4 | $1.37M | Sell |
40,435
-26,772
| -40% | -$906K | ﹤0.01% | 2935 |
|
|
2020
Q3 | $1.68M | Buy |
67,207
+60,376
| +884% | +$1.51M | ﹤0.01% | 2444 |
|
|
2020
Q2 | $230K | Buy |
+6,831
| New | +$230K | ﹤0.01% | 3984 |
|